Metacrine Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Metacrine Inc (Metacrine) is a biotechnology company that conducts research in nuclear hormone receptors for the treatment of metabolic diseases. The company develops novel therapeutics for significant metabolic diseases such as type 2 diabetes and non-alcoholic steatohepatitis. It provides various mechanistically discrete programs to target diabetes, non-alcoholic steatohepatitis and other metabolic diseases and liver disorders. Metacrine offers solutions for patients which are unable to achieve target HbA1c levels and glucose control. The company collaborates with various medical institutes and research centers. Metacrine is headquartered in San Diego, California, the US.

Metacrine Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metacrine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Metacrine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Metacrine Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Metacrine Raises USD65 Million in Series C Venture Financing 10
Metacrine Raises USD22 Million in Series B Financing 12
Metacrine Raises USD36 Million in Series A Venture Financing 13
Metacrine Raises USD6.5 Million in Venture Financing 14
Partnerships 15
Metacrine Enters into Agreement with Novo Nordisk 15
Licensing Agreements 16
Metacrine Enters into Licensing Agreement with Salk Institute for Biological Studies 16
Metacrine Enters Into Licensing Agreement with Ronald Evans 17
Metacrine Inc - Key Competitors 18
Metacrine Inc - Key Employees 19
Metacrine Inc - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Product News 21
10/10/2017: Metacrines FXR Program to be Highlighted in Three Abstracts at The Liver Meeting 2017 in Washington, D.C. 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables


Metacrine Inc, Pharmaceuticals & Healthcare, Key Facts 2
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metacrine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metacrine Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Metacrine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Metacrine Raises USD65 Million in Series C Venture Financing 10
Metacrine Raises USD22 Million in Series B Financing 12
Metacrine Raises USD36 Million in Series A Venture Financing 13
Metacrine Raises USD6.5 Million in Venture Financing 14
Metacrine Enters into Agreement with Novo Nordisk 15
Metacrine Enters into Licensing Agreement with Salk Institute for Biological Studies 16
Metacrine Enters Into Licensing Agreement with Ronald Evans 17
Metacrine Inc, Key Competitors 18
Metacrine Inc, Key Employees 19

List Of Figures


Metacrine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metacrine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metacrine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Metacrine Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Metacrine Inc (Metacrine) is a biotechnology company that conducts research in nuclear hormone receptors for the treatment of metabolic diseases. The company develops novel therapeutics for significant metabolic diseases such

USD 250 View Report

Metacrine Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Metacrine Inc (Metacrine) is a clinical-stage biopharmaceutical company that focuses on the development of therapies for the treatment of patients with liver and gastrointestinal diseases. The company develops its proprietary

USD 250 View Report

Virgin Media Inc - Strategic SWOT Analysis Review

Virgin Media Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

J.L. Clark Inc - Strategic SWOT Analysis Review

J.L. Clark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available